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Abstract: Sickle cell disease (SCD) is a major public health priority throughout much of the world, 
affecting millions of people. In many regions, particularly those in resource-limited settings, SCD 
is not consistently diagnosed. In Africa, where the majority of SCD patients reside, more than 50% 
of the 0.2-0.3 million children born with SCD each year will die from it; many of these deaths are 
in fact preventable with correct diagnosis and treatment. Here we present a deep learning 
framework which can perform automatic screening of sickle cells in blood smears using a 
smartphone microscope. This framework uses two distinct, complementary deep neural networks. 
The first neural network enhances and standardizes the blood smear images captured by the 
smartphone microscope, spatially and spectrally matching the image quality of a laboratory-grade 
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benchtop microscope. The second network acts on the output of the first image enhancement neural 
network and is used to perform the semantic segmentation between healthy and sickle cells within 
a blood smear. These segmented images are then used to rapidly determine the SCD diagnosis per 
patient. We blindly tested this mobile sickle cell detection method using blood smears from 96 
unique patients (including 32 SCD patients) that were imaged by our smartphone microscope, and 
achieved ~98% accuracy, with an area-under-the-curve (AUC) of 0.998. With its high accuracy, 
this mobile and cost-effective method has the potential to be used as a screening tool for SCD and 
other blood cell disorders in resource-limited settings.  
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Introduction 
Sickle cell disease (SCD) is the most common hematologic inherited disorder worldwide and a 
public health priority1. The majority of the world’s SCD burden is in Sub-Saharan Africa, 
affecting millions of people at all ages. It is estimated that 200,000 to 300,000 children are born 
with SCD every year in Africa alone2,3. The prevalence of the disease varies across countries, 
being approximately 20% in Cameroon, Ghana and Nigeria and even rising up to 45% in some 
parts of Uganda3.  
SCD is an inherited disorder caused by a point mutation in hemoglobin formation, which causes 
the polymerization of hemoglobin and distortion of red blood cells in the deoxygenated state. As 
a result of this, the normally biconcave disc-shaped red blood cells become crescent or sickle 
shaped in people living with SCD.  These red blood cells are markedly less deformable, have 
one-tenth the life span of a healthy cell, and can form occlusions in blood vessels. Children with 
SCD also suffer from spleen auto-infarction and the burden of disease becomes significant. 
Loosing splenic function, these children are at high risk for infections at an extremely young age, 
which significantly increases mortality rates4. Due to the lack of diagnosis and treatment, over 
50% of these of children with SCD in middle and low-income countries will die5. 
Various methods have been developed for screening and diagnosis of SCD, including e.g., 
laboratory-based methods such as high performance liquid chromatography (HPLC)6, isoelectric 
focusing7, and hemoglobin extraction8. In addition to these relatively costly laboratory-based 
methods, there have been SCD diagnostic tests developed for point-of-care (POC) use9–14. These 
POC tests are mainly based on human reading, and human errors along with the storage 
requirements of these tests (involving e.g., controlled temperature and moisture to preserve 
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chemical activity/function) partially limit their effectiveness to screen SCD, especially in 
resource limited settings14.  
An alternative method used for screening of SCD involves microscopic inspection of blood 
smear samples by trained personnel. In fact, each year hundreds of thousands of blood smear 
slides are prepared in sub-Saharan Africa to make diagnosis of blood cell infections and 
disorders 15. Peripheral blood smears, exhibiting variations in e.g., the size, color, shape of the 
red blood cells can provide diagnostic information on blood disorders including SCD16. In 
addition to diagnosis, inspection of blood smears is also frequently used for evaluation of 
treatment and routine monitoring of patients17. Preparation of these blood smear slides is rather 
straight-forward (i.e., can be performed by minimally-trained personnel), rapid and inexpensive. 
However, this method requires a trained expert to operate a laboratory microscope and perform 
manual analysis once the blood smear is prepared; the availability of such trained medical 
personnel for microscopic inspection of blood smears is limited in resource scarce settings, 
where the majority of people with SCD live18. In an effort to provide a solution to this 
bottleneck, deep learning-based methods have been previously used to classify19 and segment20 
different types of red blood cells from digital images that were acquired using laboratory-grade 
benchtop microscopes equipped with oil-immersion objective lenses. However, these earlier 
works focused upon cell level detection, rather than slide level classification and therefore did 
not demonstrate patient level diagnosis or screening of SCD. 
As an alternative to benchtop microscopes, smartphone-based microscopy provides a cost-
effective and POC-friendly platform for microscopic inspection of samples, making it especially 
suitable for use in resource limited settings21–23. Smartphone microscopy has been demonstrated 
for a wide range of applications, including e.g., the imaging of blood cells24,25, detection of 
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viruses and DNA26,27, quantification of immunoassays28–31 and microplates32 among many others 
33–36. Recently, machine learning approaches have also been applied to smartphone microscopy 
images for automated classification of parasites in soil and water37,38.  
Here we present a smartphone-based microscope and machine learning algorithms that together 
form a cost-effective, portable and rapid sickle cell screening framework, facilitating early 
diagnosis of SCD even in resource-limited settings. The mobile microscope (Figure 1) utilizes an 
opto-mechanical attachment, coupled to the rear camera of a smartphone, transforming it into a 
portable microscope using external parts that cost ~$60 in total. This compact microscope design 
has sub-micron spatial resolution39 and weighs only 350 g including the smartphone itself.  
Using this cost-effective mobile microscope, we performed slide-level automated diagnosis of 
SCD by rapidly classifying thousands of red blood cells within a large field-of-view using a deep 
learning-based framework that takes <7 sec to process a blood smear slide per patient. We 
blindly tested this approach using 96 blood smears (32 of which came from individual patients 
with SCD) and achieved ~98% accuracy together with an area-under the-curve (AUC) of 0.998. 
We believe that this platform provides a robust solution for cost-effective and rapid screening of 
SCD, making it especially promising for POC use in resource-limited settings. 
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Figure 1. a) A photograph of the smartphone-based brightfield microscope. Schematic 
illustration of b) the design of the portable microscope in detail and c) the light path. d) Deep 
learning workflow for sickle cell analysis. 
 
Results 
The process of screening peripheral blood smears using our framework is illustrated in Figure 1 
(d).  Following the imaging of the patient slide with the smartphone-based microscope (Figure 
1(a,b, and c)), these smartphone images were rapidly enhanced using a deep neural network as 
shown on the left part of Figure 1(d). This network was trained to transform the lower resolution, 
spatially and spectrally aberrated images of the smartphone microscope into enhanced images 
that are virtually equivalent to the images of the same samples captured using a higher numerical 
aperture (NA) laboratory-grade benchtop microscope. During the training phase (Methods 
section), which is a one-time effort, pairs of mobile microscopy images (input to the network) 
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were cross-registered to the corresponding images of the same training samples, captured using a 
×20/0.75 NA objective-lens with a ×2 magnification adapter (i.e., ×40 overall magnification), 
which were used as ground truth image labels.  
This intermediate image transformation is essential for not only the automated blood smear 
analysis using a subsequent classification neural network (Figure 1(d)), but is also important for 
the improvement of smartphone microscopy images to a level that can be used by expert 
diagnosticians for manual inspection of the blood smears. Due to aberrations and lower 
resolution, the raw smartphone microscope images of red blood cells might be relatively difficult 
to interpret by human observers, who are traditionally trained on high-end benchtop 
microscopes. While our framework automatically performs cell classification and slide-level 
SCD diagnosis, any manual follow-up by a trained expert requires digital images that can be 
accurately interpreted. This is an important need satisfied by our image enhancement neural 
network that is specifically trained on blood smear samples to enhance the smartphone 
microscope images.  
Another major advantage of this approach is that the enhancement network standardizes the 
microscopic images of blood smears, making it easier for the second classification network 
perform its task and more accurately classify the sickle cells. Therefore, the enhancement 
network improves both the quality and the consistency of the subsequent sickle cell classification 
network by performing an image standardization at its output. It also helps us to account for 
variations between images over time. In fact, our sample collection was performed over the 
course of 3 years, and the blood smear images were captured with different smartphones (using 
the same opto-mechanical attachment, same phone manufacturer and model number), resulting 
in some variations between the acquired mobile-phone images over time. The image 
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enhancement network was trained with blood smear samples imaged over this time in order to 
account for these variations in the raw image quality of smartphone microscopy, standardizing 
the resolution and spatial as well as spectral features of the output images of the network.  
Using the structural similarity index (SSIM)40, we quantified the effectiveness of this image 
enhancement network on unique fields-of-view from the same slides that the network was 
trained with. The neural network improved the SSIM of our smartphone microscopy images 
from 0.601±0.017 (input) to 0.965±0.012 (output), where the mean and standard deviation were 
calculated for 8 smartphone microscope images, compared with the ground truth image labels 
acquired with a high NA benchtop microscope (see the Methods Section). This shows that after 
the neural network-based transformation, the intensity component of the smartphone images 
become highly similar to the benchtop microscope images. Examples of these image 
transformations can be seen in Figure 2, as well as in Figure S1(a), where direct comparisons 
between the network output and the ground truth benchtop microscope (0.75 NA) images are 
shown. 
Following the image enhancement and standardization network output, a second classification 
network was then used to segment the enhanced images into three classes of objects: normal red 
blood cells, sickle cells, and background. Using the output of this network, each patient blood 
smear slide imaged by smartphone microscopy was automatically analyzed and screened for 
SCD using 5 different fields-of-view, each covering 0.51 mm × 0.51 mm, i.e., a total of ~1.25 
mm2 area of each blood smear was processed by the classification network, screening on average 
9630 red blood cells per patient sample. Following this segmentation, the number of sickle cells 
and normal cells contained within each image were automatically counted. The patient slides 
were classified as being SCD positive if the average number of sickle cells within 5 images 
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covering a 1.25 mm2 field-of-view was above 0.5% of the total red blood cell count for that 
sample. This threshold was chosen based on the performance of the classification neural network 
in the validation dataset (separate from our blind testing data) to mostly account for sickle 
shaped healthy cells found in normal blood smears. 
After the training phase, we confirmed the accuracy of our framework by blindly testing 96 blood 
smear slides that were never seen by our networks before. Covering 96 individual patients, 32 of 
these blood smears are from SCD patients and 64 of them are from healthy individuals. These 
slides were imaged using our smartphone microscope between 2016 and 2019, and were 
anonymously obtained from existing specimen at the UCLA Medical Center; the clinical diagnosis 
of each patient sample was used as the ground truth label for each slide. In this blinded test, our 
framework achieved ~98% accuracy across these 96 blood smears, where there was one false 
positive slide and one false negative slide. As for our misclassifications, one healthy blood smear 
was found to have a significantly higher average number of sickle cells (0.64%) than the remaining 
healthy blood smears; the one false negative sample was only slightly below our 0.5% threshold, 
while exhibiting a higher percentage of sickle cells than any of the remaining normal blood smears. 
The percentage of sickle cells measured by our platform for each one of these blood smear slides 
is also listed in Table S1, and several examples of patches from these test images, as they digitally 
pass through the networks, are also shown in Figure 2. 
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Figure 2. Examples of patches from our test images that passed through the various steps of the 
automated sickle cell analysis framework. The smartphone microscopy images are first passed 
through an image enhancement and standardization network. Following this step, the images are 
segmented using a second, separate neural network. This segmentation network is in turn used to 
determine the number of normal and sickle cells within each image; 5 fields-of-view together 
covering ~1.25 mm2 is automatically screened, having on average 9630 red blood cells to make a 
diagnosis for each patient blood smear. 
We also report the receiver operating characteristic (ROC) curve of our framework in Figure 3, 
which demonstrates how the SCD diagnosis accuracy can change depending on the threshold used 
to label the blood smear slide, achieving an AUC of 0.998. 
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 Figure 3.  ROC curve demonstrating the false positive rate versus the true positive rate for our 
sickle cell detection framework.  
Discussion 
Through blind testing spanning 96 unique patient samples we have shown that the presented 
framework can consistently achieve high accuracy even using a limited training dataset. Similar 
to human diagnosticians examining blood smears under a microscope, screening through a large 
number of cells (on average 9630 red blood cells per patient sample) helped us achieve a high 
accuracy for automated diagnosis of SCD. In general, by using more training data containing a 
larger number of labeled sickle cell images, one can further improve our SCD detection accuracy 
and make it more efficient, requiring the capture of fewer smartphone images covering an even 
smaller field-of-view. On the other hand, acquiring a large training dataset with accurate labels at 
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the single cell level is a challenge in itself; in fact, single cell level ground truth labels from 
blood smear samples clinically do not exist, and are not being recorded. Although one could 
perform single cell level molecular analysis on blood samples of patients, creating a sufficiently 
large scale image library backed up with such single cell level ground truth labels would be very 
costly and time consuming. As an alternative, one can use multiple diagnosticians to establish a 
clinical ground truth at the single cell level by statistically merging the decisions made by a panel 
of diagnosticians. A similar multi-diagnostician based decision approach has previously been 
used to detect malaria infected cells in blood smears, rather than relying on a single expert41,42.  
This approach mitigates the fact that single cell level labeling which is performed by a human 
can be highly subjective and inconsistent even for highly-trained experts41. Therefore, an 
accurate patient diagnosis can be difficult to perform with only a limited number of cells 
screened per slide, particularly with diseases such as SCD, where normal/healthy blood can also 
contain cells showing sickle cell like microscopic features. For example, children with normal 
blood were shown to have on average 0.28% sickle cells43. Due to this variation, a large number 
of cells must be screened per patient slide to better evaluate the rate of occurrence and make an 
accurate diagnosis.  
Given these aforementioned challenges in obtaining large scale ground truth labeled image data 
from blood smears, our image enhancement and standardization network is particularly vital for 
SCD screening, helping the subsequent red blood cell segmentation network to better generalize 
sickle cell features and be efficient with limited training data by standardizing the input images 
that are fed into the classification network.  
In this work, the blood smear slides were classified by measuring the percentage of sickle cells 
over a field-of-view of ~1.25 mm2, covering on average 9630 red blood cells. Figure 4(a) reports 
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how our diagnostic accuracy and AUC would change as a function of the number of cells that are 
screened per patient, further demonstrating the importance of inspecting a large sample field-of-
view, and therefore a large number of cells for accurate SCD diagnosis (see the Methods 
section).  Without inspecting an average of a few thousand red blood cells per patient slide, the 
accuracy of our automated SCD screening platform can drop significantly. Figure 4(b) also 
reports how the ROC curves are impacted as a function of the number of cells being screened per 
patient slide, confirming the same conclusion that both the sensitivity and the specificity of the 
test steadily drop as the number of inspected cells decreases. 
 
Figure 4.  a) Plot of how the accuracy and AUC change as a function the number of cells (and 
the blood smear area) inspected by our method. b) ROC curves for various simulated blood 
smear areas. These plots (except the 1.25 mm2 one, which is our experimental result) are based 
on the average of 1000 Monte Carlo simulations performed by removing the red blood cells from 
the imaging fields-of-view at random to change the number of cells inspected by our method. As 
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the cells are relatively monodisperse, this random removal of the cells simulates a reduction in 
the inspected blood smear area per patient. 
Our results and analysis demonstrate that the presented method, enabled by smartphone 
microscopy and deep learning, is robust to perform SCD diagnosis by automated processing of 
blood smears. Furthermore, the test is rapid, cost-effective, and the required sample preparation 
is minimal, which is being routinely performed even in resource limited settings, resulting in 
hundreds of thousands of blood smears prepared per year just in sub-Saharan Africa44. Our 
method is also quite fast to compute an answer: each one of the 5 images passes through the 
neural networks in 1.37 seconds using a single Nvidia 1080 Ti GPU. This results in a total 
analysis time of 6.85 sec per patient, which is significantly faster than any manual inspection by 
experts.  While in the current implementation the analysis is performed on a computer (which 
can be a local or remote server), a smartphone application could be also used to perform the 
processing on the phone itself with an increase in the slide processing time. 
 
Materials and Methods 
Study design 
The objective of the research was to perform automated diagnosis of SCD using blood smear slides 
imaged with a smartphone-based microscope and analyzed by deep learning. The test dataset was 
made up of 96 unique patient samples involving 32 SCD thin blood smears and 64 normal thin 
blood smears. The blood smears were obtained from the UCLA Ronald Reagan Hospital, and no 
sample selection criterion was applied. Both the normal and SCD blood smears came from patients 
with a mix of gender and wide range of ages (<5 years to >60 years old). 
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Ethics approval and consent to participate 
De-identified blood smears from existing human samples were obtained from the UCLA Ronald 
Reagan Hospital. No patient information, or any link to it, was disclosed to the research team. 
General consent for the samples to be used for research purposes was obtained. Due to these 
factors, no specific IRB from UCLA was required. 
 
Design of the smartphone-based brightfield microscope 
We used a Nokia Lumia 1020 smartphone attached to a custom-designed 3D-printed unit to 
capture images of the blood smear slides. An RGB light emitting diode (LED) ring (product no. 
1643, Adafruit) was utilized to illuminate the sample in a transmission geometry and a 
microcontroller (product no. 1501, Adafruit) was used to adjust the illumination intensity. To 
ensure uniform illumination of the sample, a diffuser (product no. SG 3201, American Optic 
Supply, Golden, CO, USA) was placed in between the LEDs and the specimen. An external lens 
with a focal length of 2.6 mm (LS-40166 – M12xP0.5 Camera Lens) was used for magnification 
and was coupled to the rear camera of the smartphone. This design has a field of view of ~ 1 mm2 
per image. However, each one of our mobile phone images is cropped to the center ~0.5x0.5 mm2 
in order to avoid increased aberrations toward the edges of the field of view; per patient slide, we 
capture 5 independent images, covering a total of ~1.25 mm2. The microscope is also equipped 
with a custom-designed manual translational stage to laterally move the sample. This stage, which 
was also 3D-printed, also contained a microscope slide holder. In total, the smartphone-based 
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microscope weighs 350 g, including the phone itself, and the total cost of the device parts is ~ $60 
(excluding the smartphone). 
 
Imaging of thin blood smears  
We used thin blood smear slides for image analysis. Our ground truth microscope images were 
obtained using a scanning benchtop microscope (model: Aperio Scanscope AT) at the Digital 
Imaging Laboratory of the UCLA Pathology Department. The standard smartphone camera 
application was used to capture the corresponding input images using the smartphone-based 
microscope, using auto focus, ISO 100, and auto exposure.  
Areas of the samples captured using the smartphone microscope were co-registered to the 
corresponding fields-of-view captured using the benchtop microscope (please refer to “Image co-
registration” in Methods section for details). Three board-certified medical doctors labelled the 
sickle cells within the images captured using the benchtop microscope using a custom-designed 
graphical user interface (GUI). As the images are co-registered, these labels were used to mark 
the locations of the sickle cells within the smartphone images, forming our training image 
dataset. We captured the images on the feathered edges of the blood smear slides, where the cells 
are dispersed as a monolayer. 
Images from blood smears containing cells which have been scraped and damaged were 
excluded from the dataset, as the cut cells can appear similar to sickle cells (see e.g., Figure S2). 
One normal blood smear was accordingly excluded as we were unable to capture a sufficient 
number of usable fields-of-view due to the poor quality of the blood smear, with many scratches 
on its surface. Blood smears from four patients who were tested positive for SCD and were 
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taking medicine for treatment were also excluded from the study since their smears did not 
contain sickle cells when viewed by a board-certified medical expert.  
 
Image co-registration 
The co-registration between the smartphone microscope images and those taken by the clinical 
benchtop microscope (NA=0.75) was done using a series of steps. For the first step, these images 
are scaled to match one another by bicubically down-sampling the benchtop microscope image 
to match the size of those taken by the smartphone. Following this, they are roughly matched 
using an algorithm which creates a correlation matrix between each smartphone image and the 
stitched whole slide image captured using the benchtop lab-grade microscope. The area with the 
highest correlation is the field of view which matches the smartphone microscope image and is 
cropped from the whole slide image. An affine transformation was then calculated using 
MATLAB’s (Release R2018a, The MathWorks, Inc.) multimodal registration framework which 
extracts feature vectors and matches them to further correct the size, shift, shear, and account for 
any rotational differences45. Finally, the images were matched to each other using an elastic 
pyramidal registration algorithm to match the local features39. This step accounts for the 
spherical aberrations, which are extensive due to the nature of the inexpensive optics coupled to 
the smartphone camera. This algorithm co-registers the images at a subpixel level by 
progressively breaking the image up into smaller and smaller blocks and uses cross-correlation to 
align them. 
 
Image enhancement neural network 
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Due to the variations among the images taken by the smartphone microscope, a neural network is 
used to standardize images and improve their quality in terms of spatial and spectral features. 
These variations stem from e.g., changing exposure time, aberrations (including defocus), 
chromatic aberrations due to source intensity instability, mechanical shifts, etc. Some examples 
of the image variations that these aberrations create can be seen in Figure S3. The quality of the 
images taken by a smartphone microscope can be improved and transformed so that they closely 
resemble those taken with a state-of-the-art benchtop microscope by using a convolutional neural 
network39. Our image normalization and enhancement network uses the U-net architecture as 
shown in Figure 5 (a)46. The U-net is made up of three “down-blocks” followed by three “up-
blocks”. Each one of these blocks is made up of three convolutional layers, which use a 3×3 
convolution kernel and a stride of one. In the case of the down-block, the second of these layers 
increases the number of channels by a factor of two, while the second convolutional layer in the 
up-block reduces the number of channels by a factor of one quarter. The down-blocks are used to 
reduce the size of the images using an average pooling layer with a stride of two, so the network 
can extract and use features at different scales. The up-blocks return the images to the same size 
by bilinearly up-sampling the images by a factor of two. Between each of the blocks of the same 
size, skip connections are added to allow information to pass by the lower blocks of the U-net. 
Between the bottom blocks, a convolution layer is also added to allow processing of those large-
scale features. The first convolutional layer of the network initially increases the number of 
channels to 32, while the last one reduces the number back to the 3 channels of the RGB color 
space to match the benchtop microscope images (ground truth). 
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Figure 5. Diagram detailing the network architecture for both a) the image enhancement 
network and b) the semantic segmentation network. 
The image enhancement network is trained using a combination of two loss functions, described 
by the equation: 
𝐿𝑁𝑒𝑡𝑤𝑜𝑟𝑘 = 𝐿1{𝑧, 𝐺(𝑥)} + 𝜆 ∗ 𝑇𝑉(𝐺(𝑥))         (1) 
where an L1 (mean absolute error) loss function is used to train the network to perform an 
accurate transformation, while the total variation (TV) loss is used as a regularization term.  λ is 
a constant set to 0.03; this constant makes the total variation ~5% of the overall loss. G(x) 
represents image generated using the input image x. The L1 loss can be described by the 
following equation47: 
𝐿1{𝑧, 𝐺(𝑥)} =
1
𝑁channels × 𝑀 × 𝑁
∑ ∑ |𝐺(𝑥)𝑖,𝑗,𝑛 − 𝑧𝑖,𝑗,𝑛|
𝑀,𝑁
𝑖,𝑗=1
𝑁channels
𝑛=1
         (2) 
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Where Nchannels is the number of channels, n is the channel number, M and N are the width and 
height of the image in pixels, and i, and j are the pixel indices. The total variation loss is 
described by the following equation48: 
𝑇𝑉(𝐺(𝑥)) =
1
𝑁channels × 𝑀 × 𝑁
∑ ∑ (|𝐺(𝑥)𝑖+1,𝑗,𝑛 − 𝐺(𝑥)𝑖,𝑗,𝑛|
𝑀,𝑁
𝑖,𝑗=1
𝑁channels
𝑛=1
+ |𝐺(𝑥)𝑖,𝑗+1,𝑛 − 𝐺(𝑥)𝑖,𝑗,𝑛|)      (3) 
The network was trained for 604000 iterations (118.5 epochs), with the data augmented through 
random flips and rotations of the training images by a multiple of 90 degrees. 
For this image enhancement network training, there is no need for manual labeling of cells by a 
trained medical professional, and therefore this dataset can be made diverse very easily. Because 
of this, it can also be expanded upon quickly as all that is required is additional images of the 
slides to be captured by both microscopy modalities and co-registered with respect to each other. 
Therefore, the network was able to more easily cover the entire sample space to ensure accurate 
image normalization and enhancement. The training image dataset consisted of 520 image pairs 
coming from 10 unique blood smears. Each of these images have 1603×1603 pixels, and are 
randomly cropped into 128×128 pixel patches to train the network.  Several examples of direct 
comparisons between the network’s output and the corresponding field of view captured by the 
benchtop microscope can be seen in Figure S1(a). 
 
Mask creation for training the cell segmentation network 
Once the cells were labeled by board-certified medical experts and the images were co-
registered, the cell labels were used to create a mask which constitutes the ground truth of the 
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segmentation network; this mask creation process is a one-time training effort and used to train 
the cell segmentation neural network used in our work. These training masks were generated by 
thresholding the benchtop microscope images according to color and intensity to determine the 
locations of all the healthy and the sickle cells. The exact thresholds were chosen manually for 
each slide due to minor color variations between the blood smears; once again, this is only for 
the training phase.  As the centers of some red blood cells were the same color as the 
background, holes in the mask were filled using MATLAB’s imfill command, a morphological 
operator. Following this, the mask was eroded by four pixels in order to eliminate sharp edges 
and eliminate pixels misclassified due to noise. Any cell labeled by the medical expert as a sickle 
cell was set as a sickle cell while any unlabeled red blood cell was set as a normal cell for 
training purposes. White blood cells, platelets and the background were all labeled as a third 
background class.  As the medical experts might have randomly missed some sickle cells within 
each field of view, a 128×128 region around each labeled sickle cell was cut out of the slide for 
training, reducing the unlabeled area contained within the training dataset. The remaining 
sections of the labeled slides were removed from the training dataset. At the end of this whole 
process, which is a one-time training effort, three classes are defined for the subsequent semantic 
segmentation training of the neural network: (1) sickle, (2) normal red blood cell, and (3) 
background. 
 
Semantic segmentation 
A second deep neural network is used to perform semantic segmentation of the blood cells 
imaged by our smartphone microscope. This network has the same architecture as the first image 
enhancement network (U-net). However, as this network performs segmentation, it uses the 
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SoftMax cross entropy loss function to differentiate between the three classes (sickle cell, normal 
red blood cell, and background). In order to reduce the number of false positives as much as 
possible, the normal cell class is given twice the weight of the background and the sickle cells in 
the loss function. The overall loss function for the segmentation network, LSegmentation, is 
described in equation 4: 
𝐿𝑆𝑒𝑔𝑚𝑒𝑛𝑡𝑎𝑡𝑖𝑜𝑛 = −
1
𝑀 × 𝑁
∑ 𝑎𝑖,𝑗,1 log(𝑝𝑖,𝑗,𝑐=1) + 2𝑎𝑖,𝑗,2 log(𝑝𝑖,𝑗,𝑐=2)
𝑀,𝑁
𝑖,𝑗=1
+ 𝑎𝑖,𝑗,3 log(𝑝𝑖,𝑗,𝑐=3)     (4) 
where M and N are the number of pixels in an image, and i, and j are the pixel indices as above. 
ai,j,c is the ground-truth binary label for each pixel (i.e., 1 if the pixel belongs to that class, 0 
otherwise), and c denotes the class number (c={1,2,3}), where the first class represents the 
background, the second class is for healthy cells, and the third class is for sickle cells. The 
probability pi,j,c that a class c is assigned to pixel i,j is calculated using the softmax function:  
𝑝𝑖,𝑗,𝑐 =
exp(𝑦𝑖,𝑗,𝑐)
∑ exp(𝑦𝑖,𝑗,𝑘)
3
𝑘=1
                                                                            (5) 
where y is the output of the neural network. 
 A visual representation of the network architecture can be seen in Figure 5(b). Several examples 
of direct comparisons between the network’s output at the single cell level and the corresponding 
field of view imaged by the clinical benchtop microscope can be seen in Figure S1(a).  
The training dataset for this network was made up of 2660 sickle cell image patches (each 
128×128 pixels) from a single blood smear slide, each one containing a unique labeled sickle 
cell. An additional 3177 image patches (each 128×128 pixels) coming from 15 unique slides 
containing solely normal cells were also used. Separate from our blind testing image dataset 
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which involved 96 unique patients, 250 labeled 128×128-pixel sickle cell image patches and two 
1500×1500-pixel images from healthy image slides were used as validation dataset for the 
network training phase. The classification algorithm was validated using these images alongside 
5 unique fields-of-view from 10 additional blood smear slides of healthy patients. 
 
 
 
Classification of blood smear slides 
Once the images have been segmented by the second neural network, the number of total cells 
and sickle cells must be extracted. The algorithm first uses a threshold to determine which pixels 
are marked as cells. Areas where the sum of the sickle cell and normal cell probabilities is above 
0.8 are considered to be part of a red blood cell, while areas below this threshold are considered 
as background regions. Connected areas which contain more than 100 pixels above the 0.8 
threshold are then counted to determine the total number of cells. Sickle cells are counted using a 
similar methodology: connected areas where there are over 100 pixels above a sickle cell 
probability threshold of 0.15 were counted as sickle cells. This threshold is set to be low since 
significantly more number of healthy red blood cells is used to train the network. A slide is 
classified as being positive for sickle cell disease when the percentage of sickle cells among all 
the inspected cells (sickle and normal red blood cells) over a total field-of-view of ~1.25 mm2 is 
above 0.5%. The 0.5% threshold was chosen using the validation image dataset, i.e., it was based 
on the network’s performance in classifying the 10 healthy validation slides to account for false 
positives and the occurrence of sickle shaped cells in normal blood smears. Several examples of 
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direct comparisons between the network’s output and the ground truth labels for blindly tested 
regions of the labeled slides are shown in Figure S1(b). 
 
Structural similarity calculations 
The SSIM calculations were performed using only the brightness (Y) component of the YCbCr 
color space as we expect the intensity contrast component to remain similar, while the chroma 
components (Cb, Cr) to depend on other factors, including variability in the slide’s staining. The 
calculations were performed upon 8 unique fields-of-view from the same slides which were used 
to train the enhancement network. SSIM is calculated using the equation: 
𝑆𝑆𝐼𝑀(𝑥, 𝑧) =
(2𝜇𝑥𝜇𝑧 + 𝑐1)(2𝜎𝑥,𝑧 + 𝑐2)
(𝜇𝑥2 + 𝜇𝑧2 + 𝑐1)(𝜎𝑥2 + 𝜎𝑧2 + 𝑐2)
                       (6) 
where x and z represent the two images being compared, as above. µx and µz represent the 
average values of x and y respectively, and σx and σz are the variance of x and z, and σz is the 
covariance of x and z. c1 and c2 are dummy variables, which stabilize the division from a small 
denominator. 
 
Monte Carlo simulation details 
The Monte Carlo simulations reported in Figure 4 demonstrate how the accuracy of the presented 
technique changes as a function of the number of cells analyzed by our neural networks; these 
simulations were implemented by beginning with the full cell count from the 5 fields-of-view 
tested for each patient slide. This total cell count was reduced by randomly eliminating some of 
the cells to evaluate the impact of the number of cells analyzed on our accuracy. As the cells are 
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relatively monodisperse, this random removal of red blood cells was used as an approximation of 
a reduction of the inspected blood smear area per patient. The results of 1000 simulations were 
averaged since the accuracy can fluctuate significantly, particularly at low numbers of cells. The 
total number of cells within the 5 fields-of-view that we used for SCD diagnosis varies from 
4105 to 13989. 
 
Implementation details 
The neural networks were trained using Python 3.6.2 and the TensorFlow package version 1.8.0. 
The networks were trained and test images were processed on a desktop computer running 
Windows 10 using an Intel I9-7900X CPU, 64 GB of RAM and one of the computer’s two GPUs 
(NVIDA GTX 1080 Ti). The enhancement network infers each field of view in 0.73 seconds 
while the classification network inference takes 0.64 seconds per field of view, taking a total of 
6.85 sec to process the entire 1.25 mm2 area of the blood smear. For both of the neural networks, 
the training image data were augmented by using random rotations and flipping. 
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